• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

严重急性呼吸综合征冠状病毒 2 顺势疗法制剂:一种有潜力的替代疫苗平台。

Severe Acute Respiratory Syndrome Coronavirus 2 Nosode: A Potential Alternative Vaccine Platform.

机构信息

Department of Oral Medicine and Radiology, Malla Reddy Institute of Dental Sciences, Hyderabad, Telangana, India, Phone: +91 9701806830, e-mail:

Dr Reddy's Institute of Life Sciences, University of Hyderabad Campus, Hyderabad, Telangana, India.

出版信息

J Contemp Dent Pract. 2022 Feb 1;23(2):133-134.

PMID:35748439
Abstract

Besides conventional vaccinations, viable alternatives are needed to elicit an immune response against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We propose and highlight the value of a homeopathic approach known as the "nosode" for the prevention of coronavirus disease-2019 (COVID-19). Nosode is an extract prepared from disease-affected tissues which is subsequently processed and administered as an antidote for the same medical condition. This concept might be a crucial therapeutic approach for viral infections since infected tissues contain a wide range of important viral antigens that could induce a functional host response via immunological sensitization. Thereby, nosode preparation produced from SARS-CoV-2-affected tissues may provide protection against COVID-19. "SARS-CoV-2 nosode" warrants more scientific investigation as a viable alternative vaccination platform. Keywords: COVID-19, Nosode, SARS-CoV-2, Variolation.

摘要

除了常规疫苗接种外,还需要可行的替代方法来引发针对严重急性呼吸综合征冠状病毒 2 (SARS-CoV-2) 的免疫反应。我们提出并强调了一种顺势疗法方法的价值,称为“顺势疗法疗法”,用于预防 2019 年冠状病毒病 (COVID-19)。顺势疗法疗法是一种从受疾病影响的组织中提取的提取物,随后经过处理并作为同一医疗条件的解毒剂进行给药。这一概念可能是治疗病毒感染的关键治疗方法,因为受感染的组织中含有广泛的重要病毒抗原,这些抗原可以通过免疫致敏诱导功能性宿主反应。因此,从 SARS-CoV-2 感染组织中制备的顺势疗法疗法可能为 COVID-19 提供保护。“SARS-CoV-2 顺势疗法疗法”作为一种可行的替代疫苗接种平台,值得进一步的科学研究。关键词:COVID-19、顺势疗法疗法、SARS-CoV-2、种痘。

相似文献

1
Severe Acute Respiratory Syndrome Coronavirus 2 Nosode: A Potential Alternative Vaccine Platform.严重急性呼吸综合征冠状病毒 2 顺势疗法制剂:一种有潜力的替代疫苗平台。
J Contemp Dent Pract. 2022 Feb 1;23(2):133-134.
2
Insights into COVID-19 Vaccine Development Based on Immunogenic Structural Proteins of SARS-CoV-2, Host Immune Responses, and Herd Immunity.基于 SARS-CoV-2 的免疫原性结构蛋白、宿主免疫反应和群体免疫的 COVID-19 疫苗开发的新见解。
Cells. 2021 Oct 29;10(11):2949. doi: 10.3390/cells10112949.
3
The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.新冠病毒-19(Sars-Cov-2)的英国变体不应造成疫苗问题。
J Biol Regul Homeost Agents. 2021 Jan-Feb;35(1):1-4. doi: 10.23812/21-3-E.
4
Cross-protective immunity following coronavirus vaccination and coronavirus infection.冠状病毒疫苗接种和感染后的交叉保护免疫。
J Clin Invest. 2021 Dec 15;131(24). doi: 10.1172/JCI151969.
5
High-Resolution Linear Epitope Mapping of the Receptor Binding Domain of SARS-CoV-2 Spike Protein in COVID-19 mRNA Vaccine Recipients.新型冠状病毒刺突蛋白受体结合域线性表位在 COVID-19 mRNA 疫苗接种者中的高分辨率线性表位作图。
Microbiol Spectr. 2021 Dec 22;9(3):e0096521. doi: 10.1128/Spectrum.00965-21. Epub 2021 Nov 10.
6
Consensus summary report for CEPI/BC March 12-13, 2020 meeting: Assessment of risk of disease enhancement with COVID-19 vaccines.CEPI/BC 2020 年 3 月 12-13 日会议共识总结报告:评估 COVID-19 疫苗引起疾病增强的风险。
Vaccine. 2020 Jun 26;38(31):4783-4791. doi: 10.1016/j.vaccine.2020.05.064. Epub 2020 May 25.
7
A human cell-based SARS-CoV-2 vaccine elicits potent neutralizing antibody responses and protects mice from SARS-CoV-2 challenge.一种基于人体细胞的 SARS-CoV-2 疫苗可引发强烈的中和抗体反应,并可保护小鼠免受 SARS-CoV-2 攻击。
Emerg Microbes Infect. 2021 Dec;10(1):1555-1573. doi: 10.1080/22221751.2021.1957400.
8
Characterization of SARS-CoV-2-Specific Humoral and Cellular Immune Responses Induced by Inactivated COVID-19 Vaccines in a Real-World Setting.在真实环境中评估灭活 COVID-19 疫苗诱导的 SARS-CoV-2 特异性体液和细胞免疫应答的特征。
Front Immunol. 2021 Dec 22;12:802858. doi: 10.3389/fimmu.2021.802858. eCollection 2021.
9
[Measurement of Anti-SARS CoV-2 Antibodies following Vaccination: Valuable Monitoring or Irrelevant Tool?].[接种疫苗后抗SARS-CoV-2抗体的检测:有价值的监测手段还是无关紧要的工具?]
Anasthesiol Intensivmed Notfallmed Schmerzther. 2022 Apr;57(4):302-306. doi: 10.1055/a-1783-3932. Epub 2022 Apr 21.
10
Randomized Double-Blind, Placebo-Controlled Feasibility Study, Evaluating the Efficacy of Homeopathic Medicines in the Prevention of COVID-19 in a Quarantined Population.随机双盲、安慰剂对照可行性研究,评估顺势疗法药物在隔离人群中预防 COVID-19 的效果。
Homeopathy. 2022 Feb;111(1):49-56. doi: 10.1055/s-0041-1735235. Epub 2021 Sep 30.